Madar Shlomi, Amor Reef Einoch, Furman-Assaf Sharon, Friedman Eitan
SpotitEarly Inc., Englewood, NJ 07631, USA.
SpotitEarly Ltd., Kibbutz Hama'apil 3885700, Israel.
Cancers (Basel). 2025 Jun 2;17(11):1867. doi: 10.3390/cancers17111867.
Early detection of cancer is crucial for improving patient outcomes. Traditional modalities such as mammography and low-dose computed tomography are effective but exhibit inherent limitations, including radiation exposure and accessibility challenges. This review explores innovative, non-invasive cancer screening methods, focusing on liquid biopsy and volatile organic compound (VOC)-based detection platforms. Liquid biopsy analyzes circulating tumor DNA and other biomarkers in bodily fluids, offering potential for early detection and monitoring of treatment response. VOC-based detection leverages unique metabolic signatures emitted by cancer cells, detectable in exhaled breath or other bodily emissions, providing a rapid and patient-friendly screening option. We provide a comprehensive overview of these advanced multi-cancer detection techniques to enhance diagnostic accuracy, accessibility, and patient adherence, and ultimately enhance survival rates and patient outcomes.
癌症的早期检测对于改善患者预后至关重要。传统的检测方式,如乳房X光检查和低剂量计算机断层扫描,虽然有效,但存在固有的局限性,包括辐射暴露和可及性挑战。本综述探讨了创新的非侵入性癌症筛查方法,重点关注液体活检和基于挥发性有机化合物(VOC)的检测平台。液体活检分析体液中的循环肿瘤DNA和其他生物标志物,为癌症的早期检测和治疗反应监测提供了可能。基于VOC的检测利用癌细胞发出的独特代谢特征,可在呼出气体或其他身体排放物中检测到,提供了一种快速且对患者友好的筛查选择。我们全面概述了这些先进的多癌检测技术,以提高诊断准确性、可及性和患者依从性,并最终提高生存率和改善患者预后。